Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 6;24(5):5015.
doi: 10.3390/ijms24055015.

Treatment Strategy of Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Review of Recent Evidence

Sung-Dong Kim  1 , Kyu-Sup Cho  1
Affiliations
Review

Treatment Strategy of Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Review of Recent Evidence

Sung-Dong Kim et al. Int J Mol Sci. .

Abstract

Chronic rhinosinusitis (CRS) is recognized as a heterogeneous disease with a wide range of clinical features, resulting in significant morbidity and cost to the healthcare system. While the phenotypic classification is determined by the presence or absence of nasal polyps and comorbidities, the endotype classification has been established based on molecular biomarkers or specific mechanisms. Research on CRS has now developed based on information based on three major endotypes: types 1, 2, and 3. Recently, biological therapies targeting type 2 inflammation have been clinically expanded and may be applied to other inflammatory endotypes in the future. The purpose of this review is to discuss the treatment options according to the type of CRS and summarize recent studies on new therapeutic approaches for patients with uncontrolled CRS with nasal polyps.

Keywords: biologics; chronic rhinosinusitis; endotype; nasal polyps; pharmacotherapy; surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Dietz de Loos D., Lourijsen E.S., Wildeman M.A.M., Freling N.J.M., Wolvers M.D.J., Reitsma S., Fokkens W.J. Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology. J. Allergy Clin. Immunol. 2019;143:1207–1214. doi: 10.1016/j.jaci.2018.12.986. - DOI - PubMed
    1. Tomassen P., Vandeplas G., Van Zele T., Cardell L.O., Arebro J., Olze H., Forster-Ruhrmann U., Kowalski M.L., Olszewska-ziaber A., Holtappels G., et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J. Allergy Clin. Immunol. 2016;137:1449–1456. doi: 10.1016/j.jaci.2015.12.1324. - DOI - PubMed
    1. Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S., Cohen N., Cervin A., Douglas R., Gevaert P., et al. EPOS 2012, European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50:1–12. doi: 10.4193/Rhino12.000. - DOI - PubMed
    1. Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S., Cohen N., Cervin A., Douglas R., Gevaert P., et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58((Suppl. S29)):1–464. doi: 10.4193/Rhin20.401. - DOI - PubMed
    1. Song W.J., Lee J.H., Won H.K., Bachert C. Chronic rhinosinusitis with nasal polyps in older adults, clinical presentation, pathophysiology, and comorbidity. Curr. Allergy Asthma Rep. 2019;19:46. doi: 10.1007/s11882-019-0880-4. - DOI - PubMed